Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print Cited Medium: Print ISSN: 0261-4189 (Print) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE
- Publication Information:
Publication: 2024- : [London] : Nature Publishing Group
Original Publication: Eynsham, Oxford, England : Published for the European Molecular Biology Organization by IRL Press, [c1982-
- Subject Terms:
- Abstract:
Prion diseases are characterized by accumulation of misfolded prion protein (PrP(Sc)), and neuronal death by apoptosis. Here we show that nanomolar concentrations of purified PrP(Sc) from mouse scrapie brain induce apoptosis of N2A neuroblastoma cells. PrP(Sc) toxicity was associated with an increase of intracellular calcium released from endoplasmic reticulum (ER) and up-regulation of several ER chaperones. Caspase-12 activation was detected in cells treated with PrP(Sc), and cellular death was inhibited by overexpression of a catalytic mutant of caspase-12 or an ER-targeted Bcl-2 chimeric protein. Scrapie-infected N2A cells were more susceptible to ER-stress and to PrP(Sc) toxicity than non-infected cells. In scrapie-infected mice a correlation between caspase-12 activation and neuronal loss was observed in histological and biochemical analyses of different brain areas. The extent of prion replication was closely correlated with the up-regulation of ER-stress chaperone proteins. Similar results were observed in humans affected with sporadic and variant Creutzfeldt-Jakob disease, implicating for the first time the caspase-12 dependent pathway in a neurodegenerative disease in vivo, and thus offering novel potential targets for the treatment of prion disorders.
- Comments:
Erratum in: EMBO J. 2021 Sep 15;40(18):e109151. doi: 10.15252/embj.2021109151. (PMID: 34523135)
- References:
J Gen Virol. 1984 Dec;65 ( Pt 12):2191-8. (PMID: 6439820)
Cell Mol Life Sci. 2003 Jan;60(1):133-43. (PMID: 12613663)
Nature. 1993 Apr 8;362(6420):543-6. (PMID: 8464494)
Arch Biochem Biophys. 1994 Feb 1;308(2):454-60. (PMID: 8109975)
Brain Pathol. 1996 Apr;6(2):127-45. (PMID: 8737929)
J Biol Chem. 1997 Aug 29;272(35):21751-9. (PMID: 9268304)
J Virol. 1997 Nov;71(11):8821-31. (PMID: 9343242)
J Biol Chem. 1997 Nov 7;272(45):28461-70. (PMID: 9353306)
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83. (PMID: 9811807)
Cell. 1999 Jan 22;96(2):245-54. (PMID: 9988219)
J Biol Chem. 1999 Aug 13;274(33):23396-404. (PMID: 10438517)
Annu Rev Cell Dev Biol. 1999;15:269-90. (PMID: 10611963)
Nature. 2000 Jan 6;403(6765):29-30. (PMID: 10638735)
Nature. 2000 Jan 6;403(6765):98-103. (PMID: 10638761)
Int J Hematol. 1999 Dec;70(4):226-32. (PMID: 10643147)
Lancet. 2000 Jan 15;355(9199):192-7. (PMID: 10675119)
J Virol. 2000 May;74(9):4377-86. (PMID: 10756052)
J Biol Chem. 2000 Dec 8;275(49):38699-704. (PMID: 10970892)
J Cell Biochem. 2001;80(3):441-54. (PMID: 11135374)
Arch Virol Suppl. 2000;(16):265-73. (PMID: 11214930)
Neuron. 2001 Jan;29(1):15-32. (PMID: 11182078)
Nat Rev Mol Cell Biol. 2000 Nov;1(2):120-9. (PMID: 11253364)
Mol Cell Neurosci. 2001 Mar;17(3):521-38. (PMID: 11273647)
Nature. 2001 Jun 14;411(6839):810-3. (PMID: 11459061)
J Biol Chem. 2001 Sep 7;276(36):33869-74. (PMID: 11448953)
J Biol Chem. 2001 Nov 23;276(47):43516-23. (PMID: 11533027)
J Biol Chem. 2001 Nov 23;276(47):44117-28. (PMID: 11546793)
J Cell Sci. 2001 Dec;114(Pt 23):4161-72. (PMID: 11739649)
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2696-701. (PMID: 11880624)
Hum Mol Genet. 2002 Jun 15;11(13):1505-15. (PMID: 12045204)
Biochem Biophys Res Commun. 2002 May 3;293(2):722-6. (PMID: 12054529)
J Biol Chem. 2002 Jun 14;277(24):21836-42. (PMID: 11919205)
Nat Rev Drug Discov. 2002 Feb;1(2):111-21. (PMID: 12120092)
J Biol Chem. 2002 Oct 11;277(41):38972-7. (PMID: 12163492)
J Cell Sci. 2002 Dec 1;115(Pt 23):4671-83. (PMID: 12415011)
Neurosci Lett. 2002 Dec 16;334(3):196-200. (PMID: 12453628)
Nat Rev Neurosci. 2003 Jan;4(1):49-60. (PMID: 12511861)
J Virol. 1988 May;62(5):1558-64. (PMID: 3282080)
- Accession Number:
0 (Amino Acid Chloromethyl Ketones)
0 (Caspase Inhibitors)
0 (Enzyme Inhibitors)
0 (PrPSc Proteins)
0 (Proto-Oncogene Proteins c-bcl-2)
0 (Recombinant Proteins)
0 (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
EC 3.4.22.- (CASP12 protein, human)
EC 3.4.22.- (Casp12 protein, mouse)
EC 3.4.22.- (Caspase 12)
EC 3.4.22.- (Caspases)
SY7Q814VUP (Calcium)
- Publication Date:
Date Created: 20031009 Date Completed: 20040109 Latest Revision: 20220410
- Publication Date:
20250114
- Accession Number:
PMC213791
- Accession Number:
10.1093/emboj/cdg537
- Accession Number:
14532116
No Comments.